Back
NLS Pharmaceutics Vs. Molecular Partners AG Industry Stock Comparison
Sell
31
NLSP
NLS Pharmaceutics
Last Price:
3.46
Seasonality Move:
22.75%
Sell
21
MOLN
Molecular Partners AG
Last Price:
5.51
Seasonality Move:
18.97%
Sell
31
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.90. The Score for NLSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Molecular Partners AG (MOLN)
is a Sell
Is Molecular Partners AG a Buy, Sell or Hold?
- The current Molecular Partners AG [MOLN] share price is $5.69. The Score for MOLN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- MOLN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MOLN Stock Price Chart
What is Molecular Partners AG's stock price today?
-
The Molecular Partners AG share price today is $5.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MOLN is experiencing buying pressure, which is a positive indicator for future bullish movement.
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 40.14 | Sell |
| Chaikin Money Flow: | 48222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.9 - 4.84) | Sell |
| Bollinger Bands (100): | (4.66 - 7.84) | Sell |
MOLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 49.23 | Sell |
| Chaikin Money Flow: | 2022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.04 - 6.34) | Sell |
| Bollinger Bands (100): | (5.13 - 6.91) | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.01 | Sell |
| 20-day SMA: | 4.3 | Sell |
| 50-day SMA: | 4.83 | Sell |
| 200-day SMA: | 7.91 | Sell |
| 8-day EMA: | 4.01 | Sell |
| 20-day EMA: | 4.25 | Sell |
| 50-day EMA: | 4.91 | Sell |
| 200-day EMA: | 9.74 | Sell |
MOLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.99 | Sell |
| 20-day SMA: | 5.92 | Sell |
| 50-day SMA: | 5.4 | Buy |
| 200-day SMA: | 5.16 | Buy |
| 8-day EMA: | 5.93 | Sell |
| 20-day EMA: | 5.82 | Sell |
| 50-day EMA: | 5.68 | Buy |
| 200-day EMA: | 5.44 | Buy |
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Molecular Partners AG Earnings Growth & MOLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.08 per share.
NLS Pharmaceutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Molecular Partners AG Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||